<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mesa RA</submitter><funding>NCATS NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>1211</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7194342</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>Nicastrin (NCSTN) is a transmembrane glycoprotein that is part of the gamma-secretase complex. Gamma-secretase is a protease complex that cleaves type-I single-pass transmembrane proteins. There are many potential substrates for this complex, including NOTCH receptors and amyloid precursor proteins (APP). There are a number of commercial antibodies to nicastrin, but they do not agree on expected peptide size. We confirmed the specificity of a C-terminal binding rabbit anti-human antibody from Sigma-Aldrich (#N1660) using wildtype HEK293 cells and HEK293 cells deleted for nicastrin. The wildtype cells showed a prominent band at approximately 110 kDa. We confirmed this larger than expected sized was due to glycosylation by treating the lysate with peptide-N-glycosidase F (PNGase F), which re</pubmed_abstract><journal>F1000Research</journal><pubmed_title>Validation of a commercial antibody to detect endogenous human nicastrin by immunoblot.</pubmed_title><pmcid>PMC7194342</pmcid><funding_grant_id>P30 AR073752</funding_grant_id><funding_grant_id>UL1 TR000448</funding_grant_id><pubmed_authors>Mesa RA</pubmed_authors><pubmed_authors>Roberson EDO</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation of a commercial antibody to detect endogenous human nicastrin by immunoblot.</name><description>Nicastrin (NCSTN) is a transmembrane glycoprotein that is part of the gamma-secretase complex. Gamma-secretase is a protease complex that cleaves type-I single-pass transmembrane proteins. There are many potential substrates for this complex, including NOTCH receptors and amyloid precursor proteins (APP). There are a number of commercial antibodies to nicastrin, but they do not agree on expected peptide size. We confirmed the specificity of a C-terminal binding rabbit anti-human antibody from Sigma-Aldrich (#N1660) using wildtype HEK293 cells and HEK293 cells deleted for nicastrin. The wildtype cells showed a prominent band at approximately 110 kDa. We confirmed this larger than expected sized was due to glycosylation by treating the lysate with peptide-N-glycosidase F (PNGase F), which re</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-19T17:43:50.159Z</modification><creation>2020-05-22T20:12:37Z</creation></dates><accession>S-EPMC7194342</accession><cross_references><pubmed>32399180</pubmed><doi>10.12688/f1000research.19803.2</doi></cross_references></HashMap>